Publications by authors named "R F Garberich"
Article Synopsis
- A study analyzed angiographic characteristics of patients with COVID-19 and STEMI using data from the North American COVID-19 Myocardial Infarction Registry, focusing on various angiographic outcomes.
- Among 234 patients, 74% had one major blockage (culprit lesion), with significant cases of multivessel disease and stent thrombosis, complicating treatments.
- One-third of the patients who underwent percutaneous coronary intervention (PCI) had unsuccessful outcomes linked to severe thrombus and poor blood flow, leading to higher in-hospital mortality rates for these cases.
Importance: The clinical characteristics and prognosis of patients with ST-segment elevation myocardial infarction (STEMI) with nonobstructive coronaries (MINOCA) are largely unknown.
Objective: To assess differences in 5-year mortality in patients presenting with STEMI due to MINOCA and MINOCA mimickers as compared with obstructive disease.
Design, Setting, And Participants: A retrospective analysis of a prospective registry-based cohort study of consecutive STEMI activations at 3 regional Midwest STEMI programs.
Objectives: We sought to study the association of renal impairment (RI) with mortality in ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock and/or cardiac arrest (CS/CA).
Methods: Patients with RI (estimated glomerular filtration rate <60 mL/min/1.73 m ) were identified from the Midwest STEMI consortium, a prospective registry of four large regional programs comprising consecutive patients over 17 years.
Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States.
J Soc Cardiovasc Angiogr Interv
June 2023
Background: Important health care differences exist between the United States (US) and Canada, which may have been exacerbated during the pandemic. We compared clinical characteristics, treatment strategies, and clinical outcomes of patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19 (STEMI-COVID) treated in the US and Canada.
Methods: The North American COVID-19 Myocardial Infarction registry is a prospective, investigator-initiated study enrolling patients with STEMI with confirmed or suspected COVID-19 in the US and Canada.